ACAD
Price
$19.95
Change
-$0.34 (-1.68%)
Updated
Feb 21 closing price
Capitalization
3.32B
9 days until earnings call
CCCC
Price
$3.01
Change
+$0.02 (+0.67%)
Updated
Feb 21 closing price
Capitalization
212.83M
75 days until earnings call
Ad is loading...

ACAD vs CCCC

Header iconACAD vs CCCC Comparison
Open Charts ACAD vs CCCCBanner chart's image
ACADIA Pharmaceuticals
Price$19.95
Change-$0.34 (-1.68%)
Volume$2M
Capitalization3.32B
C4 Therapeutics
Price$3.01
Change+$0.02 (+0.67%)
Volume$1.73M
Capitalization212.83M
ACAD vs CCCC Comparison Chart
Loading...
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACAD vs. CCCC commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Hold and CCCC is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 22, 2025
Stock price -- (ACAD: $20.29 vs. CCCC: $2.99)
Brand notoriety: ACAD and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 84% vs. CCCC: 71%
Market capitalization -- ACAD: $3.32B vs. CCCC: $212.83M
ACAD [@Biotechnology] is valued at $3.32B. CCCC’s [@Biotechnology] market capitalization is $212.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 0 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • ACAD’s FA Score: 0 green, 5 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, ACAD is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 5 TA indicator(s) are bullish while CCCC’s TA Score has 4 bullish TA indicator(s).

  • ACAD’s TA Score: 5 bullish, 3 bearish.
  • CCCC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ACAD is a better buy in the short-term than CCCC.

Price Growth

ACAD (@Biotechnology) experienced а +2.63% price change this week, while CCCC (@Biotechnology) price change was -6.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.57%. For the same industry, the average monthly price growth was +3.87%, and the average quarterly price growth was +3.11%.

Reported Earning Dates

ACAD is expected to report earnings on May 13, 2025.

CCCC is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+4.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACAD($3.32B) has a higher market cap than CCCC($213M). ACAD YTD gains are higher at: 10.572 vs. CCCC (-16.944). ACAD has higher annual earnings (EBITDA): 125M vs. CCCC (-103.45M). ACAD has more cash in the bank: 565M vs. CCCC (256M). ACAD has less debt than CCCC: ACAD (49.4M) vs CCCC (67.1M). ACAD has higher revenues than CCCC: ACAD (929M) vs CCCC (33.7M).
ACADCCCCACAD / CCCC
Capitalization3.32B213M1,558%
EBITDA125M-103.45M-121%
Gain YTD10.572-16.944-62%
P/E Ratio25.56N/A-
Revenue929M33.7M2,757%
Total Cash565M256M221%
Total Debt49.4M67.1M74%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
36
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADCCCC
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 18 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACAD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRLTX18.62N/A
N/A
AMG Renaissance Large Cap Growth N
NMIAX28.60N/A
N/A
Columbia Large Cap Enhanced Core A
JEMNX9.77N/A
N/A
JHancock Emerging Markets Equity R4
HMDFX28.87N/A
N/A
Hartford MidCap F
CAISX9.89-0.02
-0.20%
Calamos International Small Cap Gr A

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-0.66%
KYMR - CCCC
60%
Loosely correlated
-0.61%
FATE - CCCC
48%
Loosely correlated
-9.65%
ACAD - CCCC
46%
Loosely correlated
+3.15%
CRBU - CCCC
46%
Loosely correlated
-1.40%
IMNM - CCCC
46%
Loosely correlated
+2.12%
More